Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,581.3
-14.7 (-0.56%)

 

  • STI Straits Times Index
    2,581.3
    -14.7 (-0.56%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,564.6
    -11.8 (-0.75%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,183.0
    -47.7 (-0.19%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,360.1
    39.4 (1.19%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,289.4
    39.8 (0.17%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,247.7
    8.4 (0.16%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,818.9M
  • Value: 1,195.1M
  • Rise: 145
  • Fall: 205
  • Unch: 458

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.036-
Yinda Infocomm0.035-
Rex Intl0.168-0.013
ChinaKundaTech0.028+0.002
FJ Benjamin^0.020+0.002
Singapore-eDev0.062-0.012
Medtecs Intl1.610+0.050
ThaiBev0.605-
Kitchen Culture0.215-0.105
AnAn Intl0.037-

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,246.6 -303.4
HSCEI 9,742.1 -111.1
Jakarta 4,863.1 -41.0
Nikkei 225 22,062.1 -450.0
SSE Comp 2,958.7 -11.9
Shanghai A 3,101.3 -12.4
Shanghai B 211.6 -1.8
KOSPI 2,098.0 -36.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Medtecs Intl MEDTECS INTERNATIONAL CORP LTD
Quotes 10 Minutes Delayed. Updated at 14 Aug 2020 17:15
Last (SGD): 1.610 Change: +0.050 High: 1.670 Remarks: CD
Remarks legend:
RemarksDescriptionRemarksDescription
SuspSuspendedIMMImmediate Delivery
PLPending ListingPAPending Announcement
DLDelistedCTConditional Trading
CWConditional When IssueWIWhen Issue
BIBuyIn OnlyJAdjust
HTrading HaltCDCum Dividend
XDEx DividendCBCum Bonus
XBEx BonusCRCum Rights
XREx RightsCOCum Offer
XOEx OfferCECum Entitlement
XEEx EntitlementCICum Interest
XIEx InterestCACum All
XAEx AllSCScripless Conversion
CIRBCircuit Breaker TriggeredCIRHHalt due to Circuit Breaker Triggered
Change (%): +3.21 Low: 1.560
Open 1.600 Yesterday's Close 1.560
Buy Price 1.610 Sell Price 1.620
Buy Volume ('000) 214.2 Sell Volume ('000) 485.5
Cumulative Volume ('000) 41,817.6 Cumulative Value 67,717,096
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a 0.00285 Trailing EPS (SGD) e 0.10052 NAV (SGD) b 0.2571
PE a 564.912 Trailing PE f 16.017 Price / NAV b 6.2622
Dividend (SGD) d - Cash In Hand (SGD) g 0.0525 Issued & Paid-up Shares c 549,411,000
Dividend Yield (%) d - Price / Cash In Hand g 30.667 Treasury Shares h -
Beta - 75 Daysi 1.242 R-Squared - 75 Days(%)i 1.58 Market Cap (M) 884.552
Beta - 500 Daysi -0.158 R-Squared - 500 Days (%)i 0.02 Enterprise Value (M) 912.255
Piotroski F Score 7 Exchange Code 546 Par Value ( USD ) 0.05000
52 Weeks Volatility (%) 145.958 6-Month VWAP 0.397 Free Float (%) -
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Manufacturing - Medical Specialties
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 13 Aug 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Medtecs Intl SGX 884.552 564.912 16.017 6.2622 -
Industry Medical & Biotechnology SGX 949.910 20.889 19.246 1.3354 2.022
Medical Specialties SGX 3,965.484 185.659 107.928 17.6040 0.271
Index FTSE ST Catalist Index SGX 77.071 30.063 88.683 0.9624 1.822
Local Peer Top Glove SGX 22,195.981 182.101 103.635 20.2269 0.284
Local Peer UG Healthcare SGX 549.060 40.966 40.969 10.5145 0.255
Local Peer Biolidics SGX 102.841 - - 9.4498 -
Local Peer Yunnan Energy SGX 43.794 - - 0.9014 -
Local Peer Annica SGX 16.675 - - 3.3333 -
Global Peer ABBOTT LABORATORIES NYSE 177,035.295 48.291 57.610 5.7896 1.314
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 163,678.905 44.285 44.166 5.4788 0.185
Global Peer DANAHER CORP NYSE 145,329.528 58.393 49.752 4.4047 0.325
Global Peer MEDTRONIC PLC NYSE 135,082.323 28.207 28.207 2.6624 2.144
Global Peer INTUITIVE SURGICAL INC NASDAQ 80,106.638 58.078 70.516 9.1650 -
Global Peer BECTON DICKINSON & CO NYSE 74,835.480 69.164 96.687 3.1155 1.120
Global Peer STRYKER CORP NYSE 70,752.902 33.967 44.193 5.5475 1.130
Global Peer BOSTON SCIENTIFIC CORP NYSE 56,025.037 11.920 14.077 3.5877 -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 48,539.320 46.365 65.276 12.6433 -
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 47,566.077 36.417 42.691 3.8669 1.752
Other Global Peers BAXTER INTERNATIONAL INC (NYSE), DEXCOM INC (NASDAQ), IDEXX LABORATORIES INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), ALCON AG (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), RESMED INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), ALIGN TECHNOLOGY INC (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), TELEFLEX INC (NYSE), HOLOGIC INC (NASDAQ), COOPER COS INC (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), TOPGLOV (Bursa), BIO RAD LABORATORIES INC (NYSE), ABIOMED INC (NASDAQ), INSULET CORPORATION (NASDAQ), STERIS PLC (NYSE), WATERS CORP (NYSE), PERKINELMER INC (NYSE), HARTA (Bursa), FISHER & PAYKEL HEALTHCARE CORP (ASX), MASIMO CORPORATION (NASDAQ), QIAGEN NV (NYSE), WEIGAO GROUP (HKEx), QUIDEL CORP (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), COCHLEAR LTD (ASX), PENUMBRA INC (NYSE), MICROPORT (HKEx), NOVOCURE LTD (NASDAQ), BRUKER CORPORATION (NASDAQ), HILL-ROM HOLDINGS INC (NYSE), TANDEM DIABETES CARE INC (NASDAQ), SUPERMX (Bursa), GLOBUS MED INC (NYSE), IRHYTHM TECHNOLOGIES INC (NASDAQ), KANGJI MEDICAL (HKEx), NEVRO CORP (NYSE), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), HAEMONETICS CORP (NYSE), NEOGEN CORP (NASDAQ), ICU MEDICAL INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), VENUS MEDTECH-B (HKEx), INARI MEDICAL INC (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), AK MEDICAL (HKEx), NUVASIVE INC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), CONMED CORP (NYSE), INOVIO PHARMACEUTICALS INC (NASDAQ), LIVANOVA PLC (NASDAQ), EBOS GROUP (ASX), CANTEL MEDICAL CORP (NYSE), PEIJIA-B (HKEx), STAAR SURGICAL CO (NASDAQ), GLAUKOS CORPORATION (NYSE), SHOCKWAVE MEDICAL INC (NASDAQ), ATRICURE INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), CAREDX INC (NASDAQ), AVANOS MEDICAL INC (NYSE), BIOTELEMETRY INC (NASDAQ), NANOSONICS LIMITED (ASX), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), LIFETECH SCI (HKEx), MESA LABORATORIES INC (NASDAQ), CIRC (HKEx), ATRION CORP (NASDAQ), KDL MEDICAL (HKEx), CERUS CORP (NASDAQ), INMODE LTD (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), HESKA CORP (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), CRYOLIFE INC (NYSE), VAPOTHERM INC (NYSE), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), INOGEN INC (NASDAQ), VERICEL CORP (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), SURMODICS INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), SI BONE INC (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), ZYNEX INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), QUOTIENT LTD (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), VIEWRAY INC (NASDAQ), AXOGEN INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), YESTAR HEALTH (HKEx), ANGIODYNAMICS INC (NASDAQ), PW MEDTECH (HKEx), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), PROFOUND MED CORP (NASDAQ), GOLDEN MEDITECH (HKEx), AROA BIOSURGERY LTD (ASX), MEDICAL DEVELOPMENT INTL (ASX), STEREOTAXIS INC (NYSE American), IRADIMED CORP (NASDAQ), ALPHA PRO TECH (NYSE American), CUTERA INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), CORMEDIX INC (NYSE American), MISONIX INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), INVACARE CORP (NYSE), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), DERMTECH INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), TELA BIO INC (NASDAQ), SIENTRA INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), FONAR CORP (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), MODERN DENTAL (HKEx), SOLENO THERAPEUTICS INC (NASDAQ), VINCENT MED (HKEx), SOLITON INC (NASDAQ), ELECTROMED INC (NYSE American), NEMAURA MEDICAL INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), INTRICOM CORP (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), PAVMED INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), BIOMERICA INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), VOLITIONRX LIMITED (NYSE American), ELECTROCORE INC (NASDAQ), LKL (Bursa), CYCLOPHARM LIMITED (ASX), EMVISION MEDICAL DEVICES LTD (ASX), NEURONETICS INC (NASDAQ), SOMNOMED LIMITED (ASX), RESAPP HEALTH LIMITED (ASX), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), DIMERIX LTD (ASX), NEPHROS INC (NASDAQ), YUNNAN ENERGY (HKEx), RESPIRI LTD (ASX), DAXOR CORP (NYSE American), MILESTONE SCIENTIFIC INC (NYSE American), CLEARPOINT NEURO INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), SDI LTD (ASX), IMPEDIMED LIMITED (ASX), SINTX TECHNOLOGIES INC (NASDAQ), CONFORMIS INC (NASDAQ), COMPUMEDICS (ASX), ONCOCYTE CORP (NYSE American), STRATA SKIN SCIENCES INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), DELCATH SYSTEMS INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), RESONANCE HEALTH LTD (ASX), KELFRED (HKEx), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), MICRO-X LTD (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), IMMUCELL CORP (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), AVINGER INC (NASDAQ), CELSION CORPORATION (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), NEOVASC INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), IRIDEX CORP (NASDAQ), INCANNEX HEALTHCARE LTD (ASX), NOVA EYE MEDICAL LIMITED (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), LIFE HEALTHCARE (HKEx), MOTUS GI HOLDINGS INC (NASDAQ), CARDIEX LTD (ASX), LBT INNOVATIONS LTD (ASX), THERMOGENESIS HOLDINGS INC (NASDAQ), OVENTUS MEDICAL LTD (ASX), NEUROTROPE INC (NASDAQ), CHF SOLUTIONS INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), CHECK-CAP LTD (NASDAQ), METALICITY LIMITED (ASX), RA MEDICAL SYSTEMS INC (NYSE), XTANT MEDICAL HLDGS INC (NYSE American), USCOM LTD (ASX), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), BIOLASE INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), MYOS RENS TECHNOLOGY INC (NASDAQ), OPTISCAN IMAGING (ASX), TENAX THERAPEUTICS INC (NASDAQ), CYANOTECH CORP (NASDAQ), DIGIRAD CORP (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), DYNATRONICS CORP (NASDAQ), ADHERIUM LIMITED (ASX), STHAI (SET), VIVEVE MEDICAL INC (NASDAQ), NEUROMETRIX INC (NASDAQ), CANCER GENETICS INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), ANALYTICA (ASX), HUAKANG BIOMED (HKEx), DORSAVI LTD (ASX), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.640
+65.98 %
10 Days -+0.710
+78.89 %
20 Days -+0.985
+157.60 %
Medium Term Return 3 Months -+1.423
+760.96 %
6 Months -+1.497
+1324.78 %
1 Year -+1.580
+5266.67 %
Long Term Return 2 Years -+1.573
+4251.35 %
3 Years -+1.561
+3185.71 %
5 Years -+1.559
+3056.86 %
Annualised Return Annualised --
+99.46 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.026 - 1.680 Change From 1 Year Low +1.584 % Change From 1 Year Low (%) +6092.31
Change From 1 Year High -0.070 % Change From 1 Year High (%) -4.17
2 Years Range 0.022 - 1.680 Change From 2 Years Low +1.588 % Change From 2 Years Low (%) +7218.18
Change From 2 Years High -0.070 % Change From 2 Years High (%) -4.17
5 Years Range 0.022 - 1.680 Change From 5 Years Low +1.588 % Change From 5 Years Low (%) +7218.18
Change From 5 Years High -0.070 % Change From 5 Years High (%) -4.17
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Group's business started in 1989 with the incorporation of Clement Textile & International Corporation in Philippines in 1989. Medtecs is an integrated healthcare product and services provider in Asia Pacific, and a manufacturer and distributor of medical consumables for the healthcare industry. Started in the Philippines in 1989, the Group has established its presence in the United States, Europe and the Asia Pacific region. Today, the Group has offices in Singapore, Hong Kong, Taiwan, the Philippines, Cambodia and China.The Group is an original product manufacturer (OPM) of a wide range of medical consumables for large multinational healthcare distributors, pharmaceutical companies and hospital groups in the United States and Europe. Major product groups manufactured by the Group include linen, hospital apparel, hospital apparel and bandages. The Group’s OPM is supported by 10 manufacturing facilities located in the Philippines (4), China (4) and one each in Cambodia and Taiwan.The Group also acts as agent to distribute other branded medical devices in Asia Paci8fic, including medical supplies and equipment such as wheel chairs, syringes, gauzes, digital thermometers, nebulizers, blood pressure monitors and others.The Group’s Taiwan Depository Receipts (TDR) was listed on the Taiwan Stock Exchange on 13 December 2002.The Company is an investment holding company incorporated in Bermuda on 26 November 1997.

IPO Performance

Listing Date 06 Oct 1999 Full Subscription Rate (x) 10.99
No of Placement Shares (M) 27.00 No of Public Offer Shares (M) 18.00 Public Offer Subscription Rate (x) 25.98
IPO Price (SGD) a 0.251 First Day Close (SGD) a 0.334 First Week Close (SGD) a 0.328
Current vs IPO Price (%) +541.43 First Day Gain (%) +33.07 First Week Gain (%) +30.68
Notes:
  1. Adjusted for the following: Bonus issue 1 for 5 on 29/04/2004

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2019 Dec 2019 Part 1(5.04 MB)
Annual Report 2018 Dec 2018 Part 1(3.96 MB)
Annual Report 2017 Dec 2017 Part 1(3.57 MB)
Part 2(0.45 MB)
Annual Report 2016 Dec 2016 Part 1(2.67 MB)
Annual Report 2015 Dec 2015 Part 1(1.52 MB)
Annual Report 2014 Dec 2014 Part 1(4.00 MB)
Annual Report 2013 Dec 2013 Part 1(3.85 MB)
Annual Report 2012 Dec 2012 Part 1(3.68 MB)
Annual Report 2011 Dec 2011 Part 1(6.92 MB)
Annual Report 2010 Dec 2010 Part 1(3.56 MB)
Annual Report 2009 Dec 2009 Part 1(2.70 MB)
Annual Report 2008 Dec 2008 Part 1(1.48 MB)
Annual Report 2007 Dec 2007 Part 1(3.26 MB)
Part 2(0.02 MB)
Annual Report 2006 Dec 2006 Part 1(7.72 MB)
Annual Report 2005 Dec 2005 Part 1(23.76 MB)
IPO Prospectus
IPO Prospectus 1999 Oct 1999 Part 1(0.12 MB)
Part 2(0.39 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
14 Aug 2020 1.600 1.670 1.560 1.610 41,817,600 1.6193
13 Aug 2020 1.430 1.680 1.430 1.560 107,228,100 1.5505
12 Aug 2020 1.230 1.450 1.060 1.410 150,562,200 1.2249
11 Aug 2020 1.000 1.010 0.975 0.975 13,293,600 0.9870
07 Aug 2020 1.010 1.020 0.965 0.970 24,321,000 0.9827
06 Aug 2020 0.990 1.030 0.985 1.000 25,749,000 1.0018
05 Aug 2020 0.990 1.050 0.980 1.010 36,902,100 1.0194
04 Aug 2020 1.030 1.040 0.945 0.985 45,987,100 0.9934
03 Aug 2020 0.945 1.020 0.945 1.010 76,752,100 0.9803
30 Jul 2020 0.865 0.920 0.850 0.900 50,244,400 0.8949
29 Jul 2020 0.885 0.890 0.840 0.850 34,157,200 0.8649
28 Jul 2020 0.775 0.880 0.770 0.875 84,793,100 0.8214
27 Jul 2020 0.755 0.775 0.745 0.765 16,102,200 0.7614
24 Jul 2020 0.775 0.775 0.740 0.750 12,283,800 0.7554
23 Jul 2020 0.750 0.775 0.745 0.760 32,044,300 0.7644
22 Jul 2020 0.765 0.765 0.725 0.730 17,919,500 0.7442
21 Jul 2020 0.730 0.790 0.690 0.745 66,748,200 0.7493
20 Jul 2020 0.665 0.740 0.645 0.735 93,436,700 0.6985
17 Jul 2020 0.510 0.625 0.495 0.625 68,493,300 0.5693
16 Jul 2020 0.665 0.675 0.520 0.520 39,808,600 0.5879
15 Jul 2020 0.685 0.695 0.595 0.645 34,022,600 0.6572
14 Jul 2020 0.650 0.720 0.605 0.635 57,499,900 0.6502
Summary
Current 2 Weeks
(30 Jul 2020 to 14 Aug 2020)
0.865 1.680 0.850 1.610 572,857,200 -
Previous 2 Weeks
(16 Jul 2020 to 29 Jul 2020)
0.665 1.680 0.520 0.850 465,786,900 -
4 Weeks from
(17 Jun 2020 to 15 Jul 2020)
0.280 1.680 0.270 0.645 1,268,869,800 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.